| 713 |
Centers for Disease Control and Prevention |
Html |
en |
Multistate Outbreak of Salmonella Chester InfectionsAssociated with Frozen Meals - 18 States, 2010 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| consuming frozen NRTE | 0.417488 |
| frozen microwave entrУЉes | 0.422802 |
| rice meal | 0.355204 |
| frozen brand | 0.374535 |
| NRTE frozen microwave | 0.503565 |
| NRTE products | 0.329485 |
| U.S. Department | 0.3467 |
| frozen foods | 0.339869 |
| rice frozen meal | 0.429299 |
| chicken product | 0.323349 |
| case-control study | 0.3939 |
| Zoonotic Infectious Diseases | 0.387375 |
| ill persons | 0.368226 |
| chicken products | 0.323431 |
| rice frozen meals | 0.753944 |
| product-specific cooking instructions | 0.407526 |
| NRTE cheesy chicken | 0.404475 |
| enterica serotype Chester | 0.64251 |
| root cause analysis | 0.398124 |
| Salmonella Chester | 0.564074 |
| food safety issues | 0.336055 |
| frozen meals | 0.978827 |
| pulsed-field gel electrophoresis | 0.397709 |
| food product packaging | 0.331048 |
| illness onset | 0.502265 |
|
| foods Food Safety | 0.330158 |
| critical control point | 0.398425 |
| Salmonella Chester infection | 0.424672 |
| multistate case-control study | 0.321505 |
| cheesy chicken | 0.895679 |
| Salmonella outbreak | 0.326341 |
| indistinguishable pulsed-field gel | 0.405294 |
| clear cooking instructions | 0.330248 |
| Salmonella Chester outbreak | 0.377581 |
| Salmonella Chester infections | 0.352559 |
| company | 0.323935 |
| outbreak strain | 0.501059 |
| safety survey microwave | 0.339638 |
| microwave wattage | 0.353063 |
| microwave standing time | 0.342421 |
| chicken cooking facility | 0.383053 |
| safe handling | 0.354831 |
| production dates | 0.353501 |
| food safety | 0.621544 |
| Salmonella enterica serotype | 0.566753 |
| microwave ovens | 0.331266 |
| comprehensive food safety | 0.336202 |
| human Salmonella enterica | 0.452934 |
| outbreak strain pulsed-field | 0.334886 |
|
CLICK HERE |
| 808 |
Centers for Disease Control and Prevention |
Html |
en |
Child Development, Young Teens (12-14 years old) - NCBDDD |
This is a time of many physical, mental, emotional, and social changes. Hormones change as puberty begins. Most boys grow facial and pubic hair and their voices deepen. |
| CDC | 0.580338 |
| challenging school work | 0.36591 |
| mental health | 0.540474 |
| age group | 0.376396 |
| Highway Traffic Safety | 0.768523 |
| young adulthood | 0.518666 |
| Blocks help parents | 0.36685 |
| Patient/parent education handouts | 0.794797 |
| Time Parenting | 0.499035 |
| Act Early. | 0.490987 |
| U.S. Department | 0.533664 |
| child immunization schedule | 0.36985 |
| children | 0.801545 |
| healthy lifestyle choices | 0.488476 |
| young children | 0.478205 |
| Health Organization information | 0.424918 |
| substance abuse | 0.46284 |
| Child Care | 0.369853 |
| Healthy Weight Information | 0.796376 |
| Traffic Safety Administration | 0.770434 |
| National Institute | 0.405784 |
| possible developmental delays | 0.480422 |
| research-based information | 0.534229 |
| mental health services | 0.441167 |
|
| fitness—using kid-friendly lingo | 0.465791 |
| motor vehicles | 0.524749 |
| various government agencies | 0.469096 |
| National Highway Traffic | 0.776438 |
| Mental Health Agency | 0.467152 |
| healthy weight | 0.892649 |
| healthy eating | 0.369103 |
| teen | 0.479617 |
| physical activity | 0.405817 |
| Bright Futures | 0.802372 |
| family members time | 0.36028 |
| site | 0.397804 |
| Parenting Toddlers | 0.355324 |
| regular check-up visit | 0.78729 |
| healthcare provider | 0.530534 |
| safety tips | 0.574229 |
| developmental stages | 0.506609 |
| information | 0.990563 |
| Healthy Children | 0.527975 |
| school bus | 0.505377 |
| safety recalls | 0.510404 |
| age | 0.524827 |
| child | 0.680539 |
|
CLICK HERE |
| 4464 |
Centers for Disease Control and Prevention |
Html |
en |
CDC - Social Media Tools for Consumers and Partners - Badges |
Resources for building campaigns and programs. Tips to help analyze and segment audiences, choose appropriate channels and tools, and evaluate messages or campaign success. |
| Centers | 0.244222 |
| reports | 0.242892 |
| health storylines | 0.49387 |
| Health Literacy | 0.659069 |
| health communication community | 0.71259 |
| journalists | 0.256791 |
| tools | 0.247363 |
| tips | 0.247697 |
| Science Digest | 0.471602 |
| Prevention | 0.244087 |
| Disease Control | 0.47272 |
| Social Marketing Practice | 0.775316 |
| appropriate channels | 0.502245 |
| social marketing campaigns | 0.788292 |
| place | 0.246861 |
| goals | 0.243683 |
| audience | 0.250691 |
|
| particular relevance | 0.478014 |
| CDC Action Plan | 0.876197 |
| resources | 0.290594 |
| easy access | 0.466022 |
| CDC Clear Communication | 0.925107 |
| efforts | 0.242255 |
| one-stop source | 0.500846 |
| health communication | 0.805219 |
| success | 0.247223 |
| research-based tool | 0.496582 |
| Plain Writing Act | 0.69791 |
| messages | 0.24714 |
| programs | 0.251267 |
| National Action Plan | 0.684188 |
| articles | 0.242947 |
| public health information | 0.735132 |
| public communication | 0.484007 |
|
CLICK HERE |
| 7138 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - United Kingdom |
null |
| Content source | 0.422709 |
| HHS | 0.297574 |
| list Skip | 0.74332 |
| endorsement | 0.291872 |
| CDC | 0.271556 |
| non-federal site | 0.4688 |
|
| Notice | 0.270187 |
| sponsors | 0.241885 |
| page options Skip | 0.947337 |
| information | 0.241652 |
| employees | 0.242118 |
|
CLICK HERE |
| 7817 |
Centers for Disease Control and Prevention |
Html |
en |
Lyme Disease - Health Communication |
Lyme Disease - Gateway to Health Communication - CDC |
| neurological abnormalities | 0.376609 |
| Lyme disease | 0.909718 |
| Lyme bacteria | 0.447152 |
| health care provider | 0.552505 |
| leaf litter | 0.443123 |
| stiff neck | 0.377547 |
| preventive antibiotics | 0.377409 |
| preventable disease | 0.39945 |
| bacteria transmission | 0.37614 |
| later disease | 0.39446 |
| overgrown grass | 0.374392 |
| health care providers | 0.424537 |
| low-lying vegetation | 0.374508 |
| Borrelia burgdorferi | 0.392624 |
| infective tick bites | 0.455382 |
| Early treatment | 0.370627 |
| classic infection | 0.373937 |
| white-footed mice | 0.386093 |
| northern Pacific coast | 0.440696 |
| highest risk | 0.374856 |
| upper midwestern states | 0.436023 |
| small mammals | 0.382224 |
| frequent sites | 0.375786 |
| insect repellant | 0.37174 |
| shady environments | 0.374231 |
|
| United States | 0.382268 |
| common vector-borne disease | 0.480212 |
| early stages | 0.435283 |
| endemic areas | 0.372083 |
| bacterial disease | 0.390298 |
| permethrin compound | 0.376874 |
| wooded areas | 0.37908 |
| muscle aches | 0.381225 |
| Lyme disease bacteria | 0.57107 |
| east coast family | 0.423642 |
| treatment failures | 0.373115 |
| Higher risk areas | 0.442497 |
| initial infection | 0.38137 |
| long sleeves | 0.373279 |
| general tiredness | 0.379399 |
| early infection | 0.376214 |
| severe manifestations | 0.375068 |
| joint pain | 0.375763 |
| people | 0.455156 |
| infected ticks | 0.419622 |
| recreation activities | 0.373607 |
| light colored clothing | 0.431957 |
| tick population | 0.39076 |
| cardiac problems | 0.376908 |
|
CLICK HERE |
| 9178 |
Centers for Disease Control and Prevention |
Html |
en |
Cervical Cancer Rates by Race and Ethnicity |
Cervical cancer incidence and mortality rates by race and ethnicity. |
| numbers | 0.421228 |
| invasive cancer sites | 0.598755 |
| NVSS | 0.424124 |
| cancer excludes basal | 0.603825 |
| genital organs | 0.500593 |
| number | 0.463046 |
| shows | 0.46358 |
| ethnic populations | 0.601836 |
| Hispanic women | 0.526669 |
| A/PI | 0.419421 |
| Indian/Alaska Native women | 0.597691 |
| registry-specific data quality | 0.585333 |
| highest rate | 0.519055 |
| Hispanic origin | 0.601906 |
| National Vital Statistics | 0.574286 |
| Behavior recode | 0.508481 |
| National Program | 0.502499 |
| incidence rate | 0.639841 |
| cervical cancer | 0.920797 |
| age groups | 0.601885 |
| graph | 0.470666 |
| Census P25–1130 | 0.604088 |
| population coverage | 0.602983 |
| data quality | 0.590945 |
| persons | 0.477805 |
|
| situ cancers | 0.502546 |
| death rates | 0.658072 |
| black women | 0.500994 |
| cervical cancer incidence | 0.690528 |
| U.S. standard population | 0.7643 |
| AI/AN | 0.41938 |
| ethnicity | 0.484815 |
| 100,000 | 0.462855 |
| skin | 0.43263 |
| USCS technical notes | 0.938698 |
| data quality criteria | 0.58474 |
| cancer registries | 0.606121 |
| potential differences | 0.596273 |
| Asian/Pacific Islander | 0.633398 |
| †Race categories | 0.599682 |
| *Rates | 0.437861 |
| National Cancer Institute | 0.607294 |
| caution | 0.509713 |
| disease | 0.421074 |
| urinary bladder | 0.501382 |
| End Results program | 0.595054 |
| squamous cell carcinomas | 0.597043 |
| U.S. population | 0.59581 |
| American Indian/Alaska Native | 0.794812 |
|
CLICK HERE |
| 10025 |
Centers for Disease Control and Prevention |
Html |
en |
Online Video Guidelines & Best Practices |
Basic information from CDC about breast cancer. |
| contact OADC DMB | 0.51631 |
| Social Media Council | 0.500629 |
| CDC’s National | 0.544392 |
| video captioning process | 0.505313 |
| YouTube Insights | 0.581535 |
| Associate Director | 0.489398 |
| larger communication goals | 0.483703 |
| Communication Services | 0.494326 |
| CDC YouTube channel | 0.897286 |
| CDC YouTube videos | 0.812008 |
| Clear Video Concept | 0.500495 |
| social media tools | 0.501474 |
| individual YouTube accounts | 0.639898 |
| CDC Web Video | 0.590898 |
| social media channels | 0.565166 |
| CDC’s YouTube | 0.738823 |
| CDC program | 0.559374 |
| communication clearance channels | 0.537823 |
| programs HCSO office | 0.484577 |
| Video Information Content | 0.521642 |
| OADC DMB | 0.58397 |
| CDC URL | 0.528154 |
| YouTube channel houses | 0.651786 |
| YouTube channel manager | 0.644253 |
|
| CDC social media | 0.578368 |
| contact socialmedia | 0.524784 |
| YouTube URL | 0.578154 |
| Digital Media Branch | 0.570491 |
| viral video sharing | 0.524484 |
| users visit YouTube | 0.642983 |
| Social Media policy | 0.506119 |
| Health Communication Science | 0.493911 |
| social media activities | 0.496954 |
| online video | 0.546221 |
| global YouTube views | 0.646284 |
| CDC Brand Identity | 0.577359 |
| video production | 0.514269 |
| CDC videos | 0.587635 |
| Basic YouTube metrics | 0.618833 |
| official YouTube channel | 0.651272 |
| CDC homepage | 0.527248 |
| social media | 0.733321 |
| YouTube video content | 0.730233 |
| health communications strategy | 0.485137 |
| CDC’s policy | 0.54078 |
| YouTube channel | 0.919542 |
| technical requirements | 0.482142 |
| online video delivery | 0.527838 |
|
CLICK HERE |
| 12634 |
Centers for Disease Control and Prevention |
Video |
en |
Director's Briefing: CRE Infections and Antibiotic Resistance |
In this Director's Briefing video, CDC Director Dr. Tom Frieden talks about drug-resistant bacteria called CRE. These bacteria pose a triple-threat: especially deadly, outsmarting our best antibiotics, and easily transfer their resistance to other germs. Patients are left with extremely limited, and in some cases, no treatment options. This Vital Signs (www.cdc.gov/vitalsigns) reports that CRE are spreading in U.S. medical facilities. More normal bacteria are becoming highly-resistant CRE. These bacteria could be the beginning of the end of antibiotics, and the entire healthcare community must act now to stop them.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at http://streaming.cdc.gov/vod.php?id=5fac59254239fa5599f8fd0fd48230ed20130304094025116 |
| Director | 0.334166 |
| Antibiotic Resistance | 0.814777 |
|
|
CLICK HERE |
| 12863 |
Centers for Disease Control and Prevention |
Html |
en |
Revised Device Labeling for the Cepheid Xpert MTB/RIF Assayfor Detecting Mycobacterium tuberculosis |
Division of Microbiology Devices, Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, Food and Drug Administration. |
| acid-fast sputum smears | 0.415593 |
| United States | 0.385381 |
| U.S. Government Printing | 0.347754 |
| original MMWR paper | 0.346314 |
| Human Services | 0.349106 |
| serial negative Xpert | 0.433423 |
| Drug Administration | 0.331017 |
| multicenter international study | 0.357985 |
| previous related MMWR | 0.350136 |
| U.S. Department | 0.348972 |
| MMWR HTML versions | 0.346945 |
| pulmonary tuberculosis | 0.456168 |
| MTB/RIF Assay result | 0.438688 |
| acid-fast stained sputum | 0.364046 |
| acid amplification testing | 0.347895 |
| smear–positive pulmonary tuberculosis | 0.371307 |
| airborne infection isolation | 0.354189 |
| electronic PDF version | 0.344507 |
| serial Xpert MTB/RIF | 0.442518 |
| culture-confirmed pulmonary tuberculosis | 0.371717 |
| additional information | 0.350788 |
| sputum specimens | 0.464617 |
| single negative Xpert | 0.427711 |
| infection control practices | 0.349203 |
|
| Xpert MTB/RIF Assay | 0.928368 |
| acid-fast bacilli | 0.334568 |
| serial collection | 0.332584 |
| Mycobacterium tuberculosis complex | 0.369032 |
| study ACTG A5295/TBTC | 0.347982 |
| MTB/RIF Assay performance | 0.403115 |
| fluorescent-stained acid-fast sputum | 0.36428 |
| ACTG A5295/TBTC | 0.351345 |
| nontuberculosis mycobacterial disease | 0.351308 |
| AFB smear | 0.366168 |
| continued AII | 0.387567 |
| single Xpert MTB/RIF | 0.436255 |
| serial sputum specimens | 0.367547 |
| negative Xpert MTB/RIF | 0.557283 |
| product labeling | 0.351378 |
| negative acid-fast sputum | 0.376729 |
| original paper copy | 0.344863 |
| human immunodeficiency virus | 0.349309 |
| smear–positive/MTBC culture-positive patients | 0.356557 |
| Concomitant acid-fast microscopy | 0.351002 |
| specific clinical circumstances | 0.350533 |
| independent FDA analysis | 0.346885 |
| MTB/RIF Assay results | 0.583639 |
|
CLICK HERE |
| 13069 |
Centers for Disease Control and Prevention |
Video |
null |
Screening for Colorectal Cancer: Optimizing Quality (CME). Primary Care Version Part 3 |
Part 3 of the Primary Care Version CME describes the role of the primary care provider in delivering high-quality colonoscopy, such as pre-procedure risk assessment, safety issues to report to the endoscopist, guidance on bowel preparation and sedation, interpreting the endoscopy report, appropriate follow-up for incomplete exams, and questions to ask the endoscopist to be sure he or she is providing high-quality exams. It is the last of three parts of a continuing education activity that provides guidance and tools for clinicians on the optimal ways to implement screening for colorectal cancer to help ensure that patients receive maximum benefit.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at
http://www.cdc.gov/cancer/videos/colorectal/quality/Primary_Care3/CRC_Screening_Optimizing_Quality_Primary_Care3_256k.mp4 |
|
|
CLICK HERE |